BeOne Medicines - EBIT 2014-2025 | ONC

BeOne Medicines - EBIT for the quarter ending March 31, 2025 was $0.011B, a 104.25% decline year-over-year.

  • BeOne Medicines - 2024 EBIT was -0.568B, a 52.95% decline from 2023.
  • BeOne Medicines - 2023 EBIT was -1.208B, a 32.52% decline from 2022.
  • BeOne Medicines - 2022 EBIT was -1.79B, a 24.39% increase from 2021.

EBIT can be defined as earnings before interest and taxes.

BeOne Medicines - EBIT 2014-2025 | ONC

  • BeOne Medicines - 2024 EBIT was -0.568B, a 52.95% decline from 2023.
  • BeOne Medicines - 2023 EBIT was -1.208B, a 32.52% decline from 2022.
  • BeOne Medicines - 2022 EBIT was -1.79B, a 24.39% increase from 2021.

EBIT can be defined as earnings before interest and taxes.